Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 27210735)

Published in Int J Pharm on May 19, 2016

Authors

Raquel Abellan-Pose1, Carmen Teijeiro-Valiño1, Manuel J Santander-Ortega2, Erea Borrajo3, Anxo Vidal3, Marcos Garcia-Fuentes1, Noémi Csaba4, María José Alonso5

Author Affiliations

1: Nanobiofar Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain.
2: Cellular Neurobiology and Molecular Chemistry of the Central Nervous System Group, University of Castilla-La Mancha, 02071 Campus of Albacete, Albacete, Spain.
3: Cell Cycle and Oncology Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain.
4: Nanobiofar Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain. Electronic address: noemi.csaba@usc.es.
5: Nanobiofar Group, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, 15706 Campus Vida, Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.